9-Amino acridines undergo reversible amine exchange reactions in water: Implications on their mechanism of action in vivo

Organic Letters

Volumn 11, Issue 21, 2009, Pages 4894-4897

  Paul, Alexis ^a   Ladame, Sylvain ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; AMINOACRIDINE DERIVATIVE; WATER;

ARTICLE; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; SYNTHESIS;

AMINES; AMINOACRIDINES; DRUG DESIGN; MODELS, CHEMICAL; MOLECULAR STRUCTURE; WATER;

EID: 70350686736     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol9019925     Document Type: Article

References (36)

1. Wainwright, M. J. Antimicrob. Chemother. 2001, 47, 1.
2. Gamage, S. A.; Figgitt, D. P.; Wojcik, S. J.; Ralph, R. K.; Ransijn, A.; Mauel, J.; Yardley, V.; Snowdon, D.; Croft, S. L.; Denny, W. A. J. Med. Chem. 1997, 40, 2634.
3. Chauhan, P. M.; Srivastava, S. K. Curr. Med. Chem. 2001, 8, 1535.
4. For a recent reviews, see: Belmont, P.; Bosson, J.; Godet, T.; Tiano, M. Anti-Cancer Agents Med. Chem. 2007, 7, 139.
5. (a) Rene, B.; Fosse, P.; Khelifa, T.; Jacquemin-Sablon, A.; Bailly, C. Mol. Pharmacol. 1996, 49, 343.
6. (b) Denny, W. A. Anti-Cancer Drug Des. 1989, 4, 241.
7. Campbell, N. H.; Parkinson, G. N.; Reszka, A. P.; Neidle, S. J. Am. Chem. Soc. 2008, 130, 6722.
8. Moore, M. J.; Schultes, C. M.; Cuesta, J.; Cuenca, F.; Gunaratnam, M.; Tanious, F. A.; Wilson, W. D.; Neidle, S. J. Med. Chem. 2006, 49, 582.
9. Acridines lacking a 9-amino substituent (e.g., DACA) have also been reported as potent anticancer drugs. For example, see: Bridewell, D. J.; Finlay, G. J.; Baguley, B. C. Anti-Cancer Drug Des. 2001, 16, 317.
10. (a) Sundquist, W. I.; Bancroft, D. P.; Lippard, S. J. J. Am. Chem. Soc. 1990, 112, 1590.
11. (b) Su, T. L.; Lin, Y. W.; Chou, T. C.; Zhang, X.; Bacherikov, V. A.; Chen, C. H.; Liu, L. F.; Tsai, T. J. J. Med. Chem. 2006, 49, 3710.
12. (c) Ma, Z.; Rao, L.; Bierbach, U. J. Med. Chem. 2009, 52, 3424.
13. (a) Burger, A. M.; Dai, F.; Schultes, C. M.; Reszka, A. P.; Moore, M. J.; Double, J. A.; Neidle, S. Cancer Res. 2005, 65, 1489.
14. (b) Oppegard, L. M.; Ougolkov, A. V.; Luchini, D. N.; Schoon, R. A.; Goodell, J. R.; Kaur, H.; Billadeau, D. D.; Ferguson, D. M.; Hiasa, H. Eur. J. Pharmacol. 2009, 602, 223.
15. (a) Su, T. L.; Chou, T. C.; Kim, J. Y.; Huang, J. T.; Ciszewska, G.; Ren, W. Y.; Otter, G. M.; Sirotnak, F. M.; Watanabe, K. A. J. Med. Chem. 1995, 38, 3226.
16. (b) Goodell, J. R.; Svensson, B.; Ferguson, D. M. J. Chem. Inf. Model. 2006, 46, 876.
17. Sebestik, J.; Safarík, M.; Stibor, I.; Hlaváček, J. Biopolymers 2006, 84, 605.
18. Carlson, C. B.; Beal, P. A. Org. Lett. 2000, 2, 1465.
19. 9-Amino-4-carboxylic acid acridines were chosen as a model system because of their high solubility in water at near-physiological pH and because of their structural analogy with drugs from the AHMA and DACA families.
20. Ma, Z.; Day, C. S.; Bierbach, U. J. Org. Chem. 2007, 27, 5387.
21. The synthesis was adapted from Redman, J. E.; Granadino-Roldán, J. M.; Schouten, J. A.; Ladame, S.; Reszka, A. P.; Neidle, S.; Balasubramanian, S. Org. Biomol Chem. 2009, 7, 76.
22. Cooper, R. G.; Magwere, T. Indian J. Med. Res. 2008, 127, 305.
23. Taetz, S.; Mürdter, T. E.; Zapp, J.; Boettcher, S.; Baldes, C.; Kleideiter, E.; Piotrowska, K.; Scharfer, U. F.; Klotz, U.; Lehr, C. M. Int. J. Pharm. 2008, 357, 6.
24. No amine exchange reaction was observed with spermidine or other primary amines that are protonated in solution at near-physiological pH of 7.4.
25. For recent reviews, see: (a) Ladame, S. Org. Biomol Chem. 2008, 6, 219.
26. (b) Lehn, J. M. Chem. Soc. Rev. 2007, 36, 151.
27. (c) Corbett, P. T.; Leclaire, J.; Vial, L.; West, K. R.; Wietor, J. L.; Sanders, J. K.; Otto, S. Chem. Rev. 2006, 106, 3652.
28. For recent examples, see: (a) Bugaut, A.; Jantos, K.; Wietor, J. L.; Rodriguez, R.; Sanders, J. K.; Balasubramanian, S. Angew. Chem., Int. Ed. 2008, 47, 2677.
29. (b) Ludlow, R. F.; Otto, S. J. Am. Chem. Soc. 2008, 130, 12218.
30. (c) Milanesi, L.; Hunter, C. A.; Sedelnikova, S. E.; Waltho, J. P. Chem. - Eur. J. 2008, 12, 1081.
31. For recent examples, see: (a) Gareiss, P. C.; Sobczak, K.; McNaughton, B. R.; Palde, P. B.; Thornton, C. A.; Miller, B. L. J. Am. Chem. Soc. 2008, 130, 16254.
32. (b) Shi, B.; Stevenson, R.; Campopiano, D. J.; Greaney, M. F. J. Am. Chem. Soc. 2006, 128, 8459.
33. For recent examples of novel reversible covalent chemistries suitable for DCC, see: (a) Saiz, C.; Wipf, P.; Manta, E.; Mahler, G. Org. Lett. 2009, 11, 3170.
34. (b) Giuseppone, N.; Schmitt, J. L.; Lehn, J. M. J. Am. Chem. Soc. 2006, 128, 16748.
35. (c) Cacciapaglia, R.; Di Stefano, S.; Mandolini, L. J. Am. Chem. Soc. 2005, 127, 13666.
36. (d) Shi, B.; Greaney, M. F. Chem. Commun. 2005, 7, 886.